Antibiotics

Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, discusses how Infectious Disease specialists, pharmacists, and nurses can work together on antimicrobial stewardship.

A recent study examines antibiotic prescribing patterns in children in primary care settings in the United Kingdom, Netherlands, and Italy.

As antibiotic-resistant Pseudomonas aeruginosa infections continue to vex healthcare settings, a new study from University of Georgia researchers offers insight on just how the pathogen works inside the human body.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses push and pull incentives that drive antibiotic development.

Microbes found in New York City park soil samples contain an array of microbes capable of producing known pathogen-fighting compounds, along with a large number of recently discovered compounds.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses global and national initiatives for the development of new antibiotics.

Researchers from the University of California-San Francisco tested the ability of 2,177 FDA-approved compounds to reduce viral proliferation in Zika-susceptible cells.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, explains the economics of antimicrobial development.

Public Health England and the Department for Environment, Food and Rural Affairs researchers in the United Kingdom found drug-resistant E. coli in a large number of chicken samples, while much lower rates of contamination were observed in beef and pork samples.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, examines the threat that antibiotic resistance poses to modern medicine.

A recent study lead by researchers from the University of Freiburg analyzed the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European hospitals.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses the economic opportunities driving the development of new pharmaceuticals.

Researchers in the United Kingdom have found that predatory bacteria can be used to safely treat antibiotic-resistant Shigella infections, which affect more than 1 million people worldwide each year.

Two cases of meningococcal disease strain B have been confirmed at Oregon State University, urging officials to take preventive measures.

Barry Kreiswirth, PhD, founding director, Public Health Research Institute Tuberculosis Center, professor of medicine at Rutgers University, examines the difficulty of developing new, effective antibiotics as more and more bacteria continue to develop resistance.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how antibiotic stewardship programs are impacting antibiotic resistance.

On their quest to put an end to a threat that may change modern medicine as we know it, researchers discovered four chemicals that disrupt AcrA, an efflux pump protein, that contributes to antibiotic resistance in bacteria.

Marcos Pires, PhD, assistant professor at Lehigh University, discusses future applications of immunotherapy.

In mid-November, the CDC released the “Core Elements of Outpatient Antibiotic Stewardship.”

A study of 100 chickens collected from a marketplace in India finds multidrug-resistance in an emerging bacterial pathogen, and has researchers calling for improved food safety, monitoring, and surveillance.

A troubling new study has reported the presence of genes that are resistant to antibiotics in air pollution.

In a new approach to fighting bacterial pathogens, Johns Hopkins University researchers have developed a new antibiotic intended to fight tuberculosis and other drug-resistant infections.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how public health institutions can work alongside private pharmaceutical companies to prevent antibiotic resistance.

A recent study has found that the rate of multidrug-resistant Pseudomonas aeruginosa infections is increasing in children in the United States.

A new service in the United Kingdom, made possible by the National Health Service, reportedly offers a fast and accurate diagnosis of bacterial throat infections, promising a new way to reduce unnecessary antibiotic prescriptions.